ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOKANDO CO.,LTD.
  3. Financials
  4. Common stock and paid-in capital

KOKANDO CO.,LTD. (E00959)

Market cap
P/E ratio
Kokan-do manufactures over-the-counter medicines like cold and stomach remedies, blending Toyama's traditional medicine heritage with modern pharmaceutical operations.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Mar 31, 20254,021+0.04%
Mar 31, 20244,019+0.00%
Mar 31, 20234,019+0.00%
Mar 31, 20224,019+0.02%
Mar 31, 20214,018+0.00%
Mar 31, 20204,018+0.01%
Mar 31, 20194,018+0.05%
Mar 31, 20184,016+0.01%
Mar 31, 20174,016+0.00%
Mar 31, 20164,016+0.00%
Mar 31, 20154,016

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat